Blood Thinners and Dental Implants: The Instruction We Won't Give
Most patients arrive braced to be told to stop their medication for a few days. Current professional guidance says close to the opposite — and the reasoning is worth understanding.
Published September 2, 2026 · Reviewed September 2, 2026
Written and medically reviewed by Dr. Sam Jain, DMD, MS, and Dr. Arpana Gupta, DDS, MDS · How we write and review this
The instruction we are not going to give you
Patients on anticoagulants tend to arrive expecting a familiar sentence: stop it three days before. It is not the sentence current guidance supports. The American Dental Association's position is that for most patients, it is not necessary to alter anticoagulation or antiplatelet therapy prior to dental intervention, and that regimens using older anticoagulants such as warfarin, and antiplatelet agents, should not be altered before dental procedures.
The reasoning is a comparison between two harms rather than a claim that bleeding does not matter. In the ADA's own framing, the risks of stopping or reducing these regimens — thromboembolism, stroke, myocardial infarction — far outweigh the consequences of prolonged bleeding, which can be controlled with local measures. Bleeding after oral surgery is visible, alarming and manageable at the chair. A stroke is none of those three.
One line on this page matters more than any other: changing an anticoagulant is never our decision alone and never yours alone. ADA guidance is that any suggested modification to the regimen before dental surgery should be made in consultation with, and on the advice of, your physician. If we ever propose one, you will hear about it after we have spoken with them — not instead of it.
Warfarin, and the number that actually decides it
For warfarin the relevant measure is the INR, which describes how far your clotting time has been extended. The evidence the ADA cites is that patients whose INR is in therapeutic range — 3.0 or less — could continue their regular warfarin regimen, and that moderately invasive oral surgery is safe at an INR of 3.5, with some experts putting the ceiling at 4.0.
So what we ask for is a recent INR. That is the entire request: not a pause, not a bridging plan, a number. How recent it needs to be depends on how stable yours runs, which your physician knows better than we do — for some patients a reading from the last few days is right, for others a stable recent history is enough. Bring what you have and we will ask your prescriber for the rest.
This is one of several reasons a surgical day gets planned in advance rather than improvised. Appointment timing, how many extractions happen in one sitting, whether a case is staged, and how the site is closed are all decisions that read differently when we know your INR history — and all of them are easier to get right on paper a week ahead than in the chair on the day.
The newer anticoagulants, and the antiplatelets
The direct oral anticoagulants — apixaban, rivaroxaban, dabigatran and edoxaban — have no INR to check, which unsettles patients who expect a number to point at. ADA guidance covers them explicitly: in most patients undergoing dental interventions, in conjunction with the usual local measures to control bleeding, no change to the anticoagulant regimen is required. Their shorter, more predictable action is part of why.
Antiplatelet drugs deserve their own paragraph, because the stakes of stopping them are highest for the patients most likely to be told to. Aspirin, clopidogrel, ticagrelor and dual antiplatelet therapy should not be interrupted prematurely — particularly after stent placement, where interrupting dual therapy before minor oral surgery is specifically not advised. Studies of invasive dental procedures in patients on single or dual antiplatelet therapy have not found a clinically significant increase in bleeding complications; where bleeding occurred, local measures handled it.
If you take more than one of these, or an anticoagulant alongside an antiplatelet, that is not a reason to expect a no. It is a reason we contact your cardiologist before planning anything, so the plan we bring back to you already has their input in it rather than a caveat attached to it.
How bleeding is controlled — at the chair, not in your pillbox
The toolkit is ordinary rather than heroic: mechanical pressure, local hemostatic agents such as absorbable gelatin sponge or oxidized cellulose, suturing, and antifibrinolytics such as tranexamic acid. These are the measures the guidance means when it says prolonged bleeding can be controlled locally, and they are prepared in advance for an anticoagulated patient rather than reached for in surprise.
Implant surgery is also frequently gentler on tissue than the extraction patients compare it to — a prepared site closes around the fixture that sits in it. That is not a promise of a bloodless afternoon, and we plan as though bleeding will need managing. Your post-operative instructions are adjusted accordingly, and the after-surgery guidance tells you what normal looks like and when to call us rather than wait.
What to bring: every anticoagulant and antiplatelet with dose and frequency, your prescriber's name, and a recent INR if you take warfarin. The rest of your medication list matters too — the full medical-history picture explains why, and if a physician's input is needed we explain how clearance actually works rather than leaving you to guess.
This article is patient education, reviewed by Dr. Sam Jain, DMD, MS, and is not a substitute for an exam. Treatment recommendations are made only after an in-person consultation and 3D imaging — the first visit is free.
